Non-alcoholic Fatty Liver Clinical Trials
2 recruiting trials for Non-alcoholic Fatty Liver. Eligibility criteria explained in plain English.
TrialFinderData lists 2 Non-alcoholic Fatty Liver clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by Ahram Canadian University (1), Cairo University (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is continuous positive airway pressure (behavioral, 1 trial), followed by free walking exercise and continuous positive airway pressure, walking free online supervised program.
Track Non-alcoholic Fatty Liver trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Free Walking Exercise in Obstructive Sleep Apnea Patients With Non-alcoholic Fatty Liver
Research evaluating the impact of continuous positive airway pressure (CPAP) \& walking exercise on fatigue severity, liver enzymes and sleeping quality in patients with...
Walking Program in Fatty Liver Children With Phenylketonuria
phenylketonuria (commonly known as PKU) is an inherited disorder that increases the levels of a substance called phenylalanine in the blood. PKU is usually associated with many...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Non-alcoholic Fatty Liver, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Non-alcoholic Fatty Liver, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Non-alcoholic Fatty Liver, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.